See how Checkpoint Therapeutics, Inc.'s FDA-approved Unloxcyt drug for cSCC is set to disrupt the market with innovative ...

They include: Pipeline and key clinical candidates for these companies: Checkpoint Therapeutics, a clinical-stage immunotherapy and targeted oncology company, focuses on the acquisition, development, ...

Oncolytics Biotech® Inc. , a leading clinical-stage company specializing in immunotherapy for oncology, today announced the presentation of two data sets through two abstracts showcasing pelareorep's ...

Immunotherapies have become a cornerstone in cancer treatment, with current therapies like checkpoint inhibitors enhancing ...

BriaCell Therapeutics Corp. operates as a clinical-stage biotechnology ... by conducting a Phase I/IIA clinical trial with Bria-IMT in combination with an immune checkpoint inhibitor and a companion ...

Broad enrollment criteria appear to have scuttled the trial, which was designed to test whether ctDNA could identify patients ...

Anaveon, a clinical stage, immuno-oncology company, today announced the appointment of Richard Sachse, M.D., Ph.D., as Chief Medical Officer effective February 1, 2025. Dr. Sachse brings more than 25 ...

Through its collaboration with Nvidia, Genesis is working to accelerate development of its AI platform, Genesis Exploration ...

USA News Group News Commentary ? The American Cancer Society recently released its Advances in Oncology ? 2024 Research Highlights report that highlighted how their scientists continued to set the ...

The Garden Grove Police Department will conduct a California driver’s license and driving under the influence (DUI) ...

Seal Beach, CA - On Wednesday, December 18, 2024, the Seal Beach Police Department will conduct a driving under the influence ...

Silexion Therapeutics (SLXN) revealed its ongoing collaboration with Evonik for the development of an advanced siRNA ...